Uptake, intracellular activity, and influence of rifampin on normal function of polymorphonuclear leukocytes
Open Access
- 1 November 1985
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 28 (5) , 667-674
- https://doi.org/10.1128/aac.28.5.667
Abstract
Quinone and hydroquinone forms of rifampin accumulated in normal polymorphonuclear leukocytes (PMN) (maximal cellular to extracellular concentration ratio [C/Emax] +/- standard error of the mean, 9.36 +/- 0.54 and 8.82 +/- 0.65, respectively, after 5 to 10 min) and chronic granulomatous disease PMN (C/Emax, 13.76 +/- 0.77 and 14.29, respectively). Uptake of rifampin was influenced by incubation temperature and extracellular pH but not by phorbol myristate acetate stimulation or metabolic inhibitors. At extracellular concentrations between 0.06 and 5.0 mg/liter, rifampin significantly reduced the number of staphylococci surviving inside chronic granulomatous disease PMN, thus compensating for the bactericidal defect inherent with this disease. Spontaneous migration and chemotaxis of normal PMN were unaffected by rifampin. However, phagocytosis of yeast particles and oxygen consumption of stimulated PMN were moderately depressed, and O2- production and chemiluminescence were significantly depressed in a dose-dependent manner. The bactericidal activity of normal PMN was not impaired. Inhibition of chemiluminescence and O2- release were also observed in a cell-free system. We conclude that rifampin possesses favorable characteristics for the effective elimination of intracellular microorganisms. Further studies are needed to evaluate the in vivo significance of ion scavenging by rifampin, which could be hazardous to immunocompromised patients.This publication has 23 references indexed in Scilit:
- Rifampin affects polymorphonuclear leukocyte interactions with bacterial and synthetic chemotaxins but not interactions with serum-derived chemotaxinsAntimicrobial Agents and Chemotherapy, 1983
- The Antimicrobial Activity of Rifampin: Emphasis on the Relation to PhagocytesClinical Infectious Diseases, 1983
- Antibiotic entry into human polymorphonuclear leukocytesAntimicrobial Agents and Chemotherapy, 1982
- The Effect of Rifamycin Sv on Neutrophil Functions in Patients with Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1982
- The respiratory burst of phagocytic cells is associated with a rise in vacuolar pHNature, 1981
- Metabolism and Pharmacokinetics of the Antibiotic RifampinDrug Metabolism Reviews, 1981
- Kinetics of oxygen consumption by phagocytosing human neutrophilsBiochemical and Biophysical Research Communications, 1978
- RIFAMPICIN AND IMMUNOSUPPRESSIONThe Lancet, 1974
- Biological Defense Mechanisms. THE PRODUCTION BY LEUKOCYTES OF SUPEROXIDE, A POTENTIAL BACTERICIDAL AGENTJournal of Clinical Investigation, 1973
- Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activityBiochemical and Biophysical Research Communications, 1972